Axsome Therapeutics
3,294
$83.059876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$83.05
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$1.12 (+1.37%) Today
+$0.01 (+0.01%) As of 8:00 PM EDT after-hours
Why Robinhood?
You can buy or sell AXSM and other stocks, options, ETFs, and crypto commission-free!
About AXSM
Axsome Therapeutics, Inc. Common Stock, also called Axsome Therapeutics, is a clinical stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Read More Its product candidates include AXS-05, AXS-07, AXS-09, AXS-12, and AXS-14 which are developing for multiple pain and primary care indications. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.
Employees
45
Headquarters
New York, New York
Founded
2012
Market Cap
3.08B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
808.61K
High Today
$83.83
Low Today
$80.03
Open Price
$81.98
Volume
306.26K
52 Week High
$109.94
52 Week Low
$13.64
Collections
Analyst Ratings
100%
of 9 ratings
Buy
100%
Hold
0%
Sell
0%
AXSM Earnings
-$0.88
-$0.59
-$0.29
$0.00
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Estimated
— per share
Actual
Expected Aug 6, Pre-Market